[go: up one dir, main page]

NO974651L - Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose - Google Patents

Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose

Info

Publication number
NO974651L
NO974651L NO974651A NO974651A NO974651L NO 974651 L NO974651 L NO 974651L NO 974651 A NO974651 A NO 974651A NO 974651 A NO974651 A NO 974651A NO 974651 L NO974651 L NO 974651L
Authority
NO
Norway
Prior art keywords
treatment
multiple sclerosis
biologically active
derivatives useful
ureido derivatives
Prior art date
Application number
NO974651A
Other languages
English (en)
Other versions
NO974651D0 (no
Inventor
Rachele Alzani
Elena Cozzi
Nicola Mongelli
Andrea Lombardi Borgia
Massimo Temponi
Francesco Colotta
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO974651D0 publication Critical patent/NO974651D0/no
Publication of NO974651L publication Critical patent/NO974651L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Anvendelse, i fremstillingen av et legemiddel for bruk i behandlingen av multippel sklerose, av en forbindelse som er et urcidoderivat av formel (I). hvor. hver av m og n. som er like, er ct heltall fra 1 til 3; og hver av R-gnippenc. som er like, er en naftylgruppc substituert med fra 1-3 sulfonsyrcgrupper. eller cl farmasoytisk akseptabelt salt derav.
NO974651A 1996-02-09 1997-10-08 Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose NO974651L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9602721.4A GB9602721D0 (en) 1996-02-09 1996-02-09 Biologically active ureido derivatives useful in the treatment of multiple sclerosis
PCT/EP1997/000412 WO1997028796A1 (en) 1996-02-09 1997-01-24 Biologically active ureido derivatives useful in the treatment of multiple sclerosis

Publications (2)

Publication Number Publication Date
NO974651D0 NO974651D0 (no) 1997-10-08
NO974651L true NO974651L (no) 1997-12-02

Family

ID=10788461

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974651A NO974651L (no) 1996-02-09 1997-10-08 Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose

Country Status (22)

Country Link
US (1) US5859046A (no)
EP (1) EP0820284B1 (no)
JP (1) JPH11504041A (no)
KR (1) KR19980703718A (no)
AR (1) AR005724A1 (no)
AT (1) ATE189388T1 (no)
AU (1) AU1720097A (no)
BR (1) BR9702075A (no)
CA (1) CA2217008A1 (no)
DE (1) DE69701243T2 (no)
DK (1) DK0820284T3 (no)
EA (1) EA000166B1 (no)
ES (1) ES2144844T3 (no)
GB (1) GB9602721D0 (no)
GR (1) GR3033332T3 (no)
HU (1) HUP9900796A2 (no)
IL (1) IL121808A0 (no)
NO (1) NO974651L (no)
PL (1) PL322717A1 (no)
PT (1) PT820284E (no)
WO (1) WO1997028796A1 (no)
ZA (1) ZA97902B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999027939A1 (en) * 1997-12-04 1999-06-10 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
US6348464B1 (en) * 1999-11-12 2002-02-19 Guilford Pharmaceuticals, Inc. Pyrrolecarbonylimino derivatives as naaladase inhibitors
ES2326083T3 (es) 2003-03-03 2009-09-30 Eisai Corporation Of North America Tiolactonas como inhibidores de naaladasa.
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
GB9307948D0 (en) * 1993-04-16 1993-06-02 Erba Carlo Spa Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Also Published As

Publication number Publication date
DE69701243T2 (de) 2000-09-07
DK0820284T3 (da) 2000-07-24
BR9702075A (pt) 1998-06-09
ATE189388T1 (de) 2000-02-15
KR19980703718A (ko) 1998-12-05
ES2144844T3 (es) 2000-06-16
GB9602721D0 (en) 1996-04-10
HUP9900796A2 (hu) 1999-07-28
PT820284E (pt) 2000-07-31
EA000166B1 (ru) 1998-10-29
CA2217008A1 (en) 1997-08-14
ZA97902B (en) 1997-08-01
WO1997028796A1 (en) 1997-08-14
MX9707673A (es) 1997-11-29
PL322717A1 (en) 1998-02-16
AR005724A1 (es) 1999-07-14
EP0820284A1 (en) 1998-01-28
US5859046A (en) 1999-01-12
GR3033332T3 (en) 2000-09-29
DE69701243D1 (de) 2000-03-09
NO974651D0 (no) 1997-10-08
JPH11504041A (ja) 1999-04-06
AU1720097A (en) 1997-08-28
IL121808A0 (en) 1998-02-22
EP0820284B1 (en) 2000-02-02
EA199700302A1 (ru) 1998-04-30

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
MD1233C2 (ro) Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
NO975632L (no) Dinukleotider som er nyttige for behandling av lungesykdom
IE811680L (en) Tri-substituted imidazole derivatives
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
EA199600104A1 (ru) Повышенная биодоступность биологически активных соединений при связывании с производными полипирролкарбоксамидонафталиновой кислоты
SE8406081D0 (sv) Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
MY107341A (en) Novel hydroxamic acid and n-hydroxyurea derivatives and their use
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
NO158017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO933611L (no) Anti-tumor- og anti-psoriatiske midler
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
NO974651L (no) Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose
MY110004A (en) Biologically active ureido derivatives useful as antimetastatic agents.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
SE9504662D0 (sv) New compounds
DE69105786D1 (de) Harnstoffderivate, deren Herstellung sowie diese enthaltende pharmazeutische Zusammensetzungen.
FI932654A0 (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
DE68906572D1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP0936218A4 (en) NEW BENZIMIDAZOLE DERIVATIVES
NO950177D0 (no) Farmakologisk aktive erivater
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные